|
PF-32792 |
SERETIDE 25/250 mcg Suspension para Inhalacion |
2014-06-02 |
|
Glaxosmithkline AG |
Francia
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-22504 |
AVAPRO 300 mg Tabletas |
2009-11-24 |
|
Sanofi Pharma Bristol-Myers Squibb SNC |
Francia
|
Centro Distribuidor S.A. |
Colon S.A. |
Agencias J.i. Cohen |
Lancasco, S.A. |
Lanquetin S.A. |
Resco S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-22503 |
AVAPRO 150 mg Tabletas |
2009-11-24 |
|
Sanofi Synthelabo Groupe |
Francia
|
Centro Distribuidor S.A. |
Colon S.A. |
Agencias J.i. Cohen |
Lancasco, S.A. |
Lanquetin S.A. |
Resco S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-36963 |
AVANDAMET 2 mg/500 mg Tabletas Recubiertas Simples |
2011-02-10 |
|
Glaxo Wellcome S.A. |
España
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37681 |
AVANDAMET 4 mg/1000 mg tabletas |
2011-07-04 |
|
Glaxosmithkline PLC |
España
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37680 |
AVANDAMET 2 mg/1000 mg tabletas |
2011-07-04 |
|
Glaxosmithkline PLC |
España
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38225 |
AVANDAMET 4 mg/500 mg tabletas |
2011-11-20 |
|
Glaxosmithkline PLC |
España
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-42834 |
FLIXOTIDE 125 mcg/dosis Suspensión para inhalación |
2024-04-22 |
|
Glaxosmithkline, S.A. |
España
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-42778 |
FLIXOTIDE 50 mcg/ dosis Suspensión para inhalación |
2024-04-07 |
|
Glaxosmithkline, S.A. |
España
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28394 |
LACIPIL 4 mg tabletas recubiertas simples |
2017-08-22 |
|
Glaxosmithkline PLC |
España
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|